Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 177

The DOI matches its Crossref record.

Two approaches to discovering and developing new drugs for Chagas disease

Open access
McKerrow, JH, Doyle, PS, Engel, JC, Podust, LM, Robertson, SA, Ferreira, R, Saxton, T, Arkin, M, Kerr, ID, Brinen, LS, Craik, CS·2009·Memórias do Instituto Oswaldo Cruz

Abstract

This review will focus on two general approaches carried out at the Sandler Center, University of California, San Francisco, to address the challenge of developing new drugs for the treatment of Chagas disease. The first approach is target-based drug discovery, and two specific targets, cytochrome P450 CYP51 and cruzain (aka cruzipain), are discussed. A 'proof of concept' molecule, the vinyl sulfone inhibitor K777, is now a clinical candidate. The preclinical assessment compliance for filing as an Investigational New Drug with the United States Food and Drug Administration (FDA) is presented, and an outline of potential clinical trials is given. The second approach to identifying new drug leads is parasite phenotypic screens in culture. The development of an assay allowing high throughput screening of Trypanosoma cruzi amastigotes in skeletal muscle cells is presented. This screen has the advantage of not requiring specific strains of parasites, so it could be used with field isolates, drug resistant strains or laboratory strains. It is optimized for robotic liquid handling and has been validated through a screen of a library of FDA-approved drugs identifying 65 hits.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1590/s0074-02762009000900034

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 177

Metadata

Authors
McKerrow, J., Doyle, P., Engel, J., Podust, L., Robertson, S., Ferreira, R., Saxton, T., Arkin, M., Kerr, I., Brinen, L., & Craik, C.
Venue
Memórias do Instituto Oswaldo Cruz
Published
2009-07
Volume
104
Issue
suppl 1
Pages
263-269
ISSN
0074-0276 (ISSN-L)
OpenAlex
W2131495602
Cited by
177
References
0
FWCI
13.98
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Two approaches to discovering and developing new drugs for Chagas disease. https://app.cochat.ai/papers/10.1590/s0074-02762009000900034
The paper
McKerrow, J., Doyle, P., Engel, J., Podust, L., Robertson, S., Ferreira, R., Saxton, T., Arkin, M., Kerr, I., Brinen, L., & Craik, C. (2009). Two approaches to discovering and developing new drugs for Chagas disease. Memórias do Instituto Oswaldo Cruz. https://doi.org/10.1590/s0074-02762009000900034

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.